标题
Recent Progresses in the Treatment of Osteoporosis
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-07-22
DOI
10.3389/fphar.2021.717065
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rheumatoid arthritis, bone and drugs: a dangerous interweave
- (2021) Salvatore Minisola et al. ANNALS OF THE RHEUMATIC DISEASES
- Silencing of miR-483-5p alleviates postmenopausal osteoporosis by targeting SATB2 and PI3K/AKT pathway
- (2021) Fujiang Zhao et al. Aging-US
- Development of selective bispecific Wnt mimetics for bone loss and repair
- (2021) Tristan W. Fowler et al. Nature Communications
- Osteoporosis Remission and New Bone Formation with Mesoporous Silica Nanoparticles
- (2021) Patricia Mora‐Raimundo et al. Advanced Science
- Overview of treatment approaches to osteoporosis
- (2020) Bente L. Langdahl BRITISH JOURNAL OF PHARMACOLOGY
- A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures
- (2020) Emil H. Schemitsch et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Aberrant Canonical Wnt signaling: Phytochemical based modulation
- (2020) Suman Manandhar et al. PHYTOMEDICINE
- MiR-1-3p regulates the differentiation of mesenchymal stem cells to prevent osteoporosis by targeting secreted frizzled-related protein 1
- (2020) Huijie Gu et al. BONE
- Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs
- (2020) N. R. Fuggle et al. DRUGS
- A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab
- (2020) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics
- (2020) Jonas Bovijn et al. Science Translational Medicine
- The Cost of Osteoporosis, Osteopenia, and Associated Fractures in Australia in 2017
- (2019) Gemma Tatangelo et al. JOURNAL OF BONE AND MINERAL RESEARCH
- RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives
- (2019) Marco Infante et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Osteoporosis
- (2019) Juliet E Compston et al. LANCET
- Wnt signaling pathway in osteoporosis: Epigenetic regulation, interaction with other signaling pathways, and therapeutic promises
- (2019) Fatemeh Amjadi-Moheb et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cardiovascular Outcomes of Romosozumab and Protective Role of Alendronate
- (2019) Kamyar Asadipooya et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cathepsin K Knockout Exacerbates Haemorrhagic Transformation Induced by Recombinant Tissue Plasminogen Activator After Focal Cerebral Ischaemia in Mice
- (2019) Rong Zhao et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis
- (2019) J. -Y. Reginster et al. OSTEOPOROSIS INTERNATIONAL
- Bone-Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment
- (2019) Pascale Chavassieux et al. JOURNAL OF BONE AND MINERAL RESEARCH
- microRNA‐96 promotes osteoblast differentiation and bone formation in ankylosing spondylitis mice through activating the Wnt signaling pathway by binding to SOST
- (2019) Shu Ma et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Sfrp4 repression of the Ror2/Jnk cascade in osteoclasts protects cortical bone from excessive endosteal resorption
- (2019) Kun Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combined low-dose LiCl and LY294002 for the treatment of osteoporosis in ovariectomized rats
- (2019) Jianhai Bai et al. Journal of Orthopaedic Surgery and Research
- New Frontiers in Osteoporosis Therapy
- (2019) Cheng Cheng et al. Annual Review of Medicine
- WNT Signaling in Disease
- (2019) Ng et al. Cells
- Secreted Frizzled‐related proteins (sFRPs) in osteo‐articular diseases: much more than simple antagonists of Wnt signaling?
- (2019) Marion Claudel et al. FEBS Journal
- Effect of Abaloparatide Versus Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis
- (2019) Benjamin Z Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab
- (2019) D.L. Kendler et al. OSTEOPOROSIS INTERNATIONAL
- Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial
- (2019) Joy N Tsai et al. Lancet Diabetes & Endocrinology
- Osteoinductive Material to Fine-Tune Paracrine Crosstalk of Mesenchymal Stem Cells With Endothelial Cells and Osteoblasts
- (2019) Hassan Rammal et al. Frontiers in Bioengineering and Biotechnology
- Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis
- (2019) Philip G. Conaghan et al. ANNALS OF INTERNAL MEDICINE
- Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysis
- (2019) Fang Lv et al. BONE
- Odanacatib: the best osteoporosis treatment we never had?
- (2019) Louise A Statham et al. Lancet Diabetes & Endocrinology
- Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
- (2019) Michael R McClung et al. Lancet Diabetes & Endocrinology
- Abaloparatide is an Effective Treatment Option for Postmenopausal Osteoporosis: Review of the Number Needed to Treat Compared with Teriparatide
- (2018) Jean-Yves Reginster et al. CALCIFIED TISSUE INTERNATIONAL
- Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study
- (2018) Michael R McClung et al. JOURNAL OF BONE AND MINERAL RESEARCH
- miR-542-3p prevents ovariectomy-induced osteoporosis in rats via targeting SFRP1
- (2018) Xiguang Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- ACTIVExtend: 24 Months of Alendronate after 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
- (2018) Henry G Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Phase 3 Randomized Placebo-controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis
- (2018) E Michael Lewiecki et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711
- (2018) Erik Lindström et al. Journal of Translational Medicine
- Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2018) David L Kendler et al. LANCET
- Epigenetic inhibition of Wnt pathway suppresses osteogenic differentiation of BMSCs during osteoporosis
- (2018) Huan Jing et al. Cell Death & Disease
- Estrogen inhibits osteoclasts formation and bone resorption via microRNA-27a targeting PPARγ and APC
- (2018) Lei Guo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Clinical advantages and disadvantages of anabolic bone therapies targeting the WNT pathway
- (2018) Natasha M. Appelman-Dijkstra et al. Nature Reviews Endocrinology
- A dual-specific macrophage colony-stimulating factor antagonist of c-FMS and αvβ3 integrin for osteoporosis therapy
- (2018) Yuval Zur et al. PLOS BIOLOGY
- Decreased microRNA-182-5p helps alendronate promote osteoblast proliferation and differentiation in osteoporosis via the Rap1/MAPK pathway
- (2018) Bao-Long Pan et al. BIOSCIENCE REPORTS
- One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study
- (2018) E Michael Lewiecki et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Activating Wnt/β-catenin signaling pathway for disease therapy: Challenges and opportunities
- (2018) Piao Huang et al. PHARMACOLOGY & THERAPEUTICS
- Administration of Momordica charantia Enhances the Neuroprotection and Reduces the Side Effects of LiCl in the Treatment of Alzheimer’s Disease
- (2018) Hei-Jen Huang et al. Nutrients
- Inhibition of osteoporosis by the αvβ3 integrin antagonist of rhodostomin variants
- (2017) Tzu-Hung Lin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Sclerostin Antibody Augments the Anabolic Bone Formation Response in a Mouse Model of Mechanical Tibial Loading
- (2017) Alyson Morse et al. JOURNAL OF BONE AND MINERAL RESEARCH
- GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation
- (2017) Mehdi Amirhosseini et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
- (2017) Bente L Langdahl et al. LANCET
- Targeting cellular senescence prevents age-related bone loss in mice
- (2017) Joshua N Farr et al. NATURE MEDICINE
- Osteoporosis: Discontinuing denosumab discouraged
- (2017) Joanna Collison Nature Reviews Rheumatology
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estrogens and Androgens in Skeletal Physiology and Pathophysiology
- (2017) Maria Almeida et al. PHYSIOLOGICAL REVIEWS
- Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1–34)
- (2017) Jacquelin Jolette et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- Glucose metabolism in bone
- (2017) Courtney M. Karner et al. BONE
- Novel Wnt Regulator NEL-Like Molecule-1 Antagonizes Adipogenesis and Augments Osteogenesis Induced by Bone Morphogenetic Protein 2
- (2016) Jia Shen et al. AMERICAN JOURNAL OF PATHOLOGY
- Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II–Induced Aortic Aneurysm and AtherosclerosisHighlights
- (2016) Smriti Murali Krishna et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Healing of osteoporotic bone defects by baculovirus-engineered bone marrow-derived MSCs expressing MicroRNA sponges
- (2016) Kuei-Chang Li et al. BIOMATERIALS
- Odanacatib, effects of 16-month treatment and discontinuation of therapy on bone mass, turnover and strength in the ovariectomized rabbit model of osteopenia
- (2016) Le T. Duong et al. BONE
- Effects of long term treatment with high doses of odanacatib on bone mass, bone strength, and remodeling/modeling in newly ovariectomized monkeys
- (2016) L.T. Duong et al. BONE
- Wnt signaling and cellular metabolism in osteoblasts
- (2016) Courtney M. Karner et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis
- (2016) Paul D. Miller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Enhancer of Zeste Homolog 2 Inhibition Stimulates Bone Formation and Mitigates Bone Loss Caused by Ovariectomy in Skeletally Mature Mice
- (2016) Amel Dudakovic et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Denosumab Reduces Cortical Porosity of the Proximal Femoral Shaft in Postmenopausal Women With Osteoporosis
- (2016) Roger Zebaze et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Merck & Co. drops osteoporosis drug odanacatib
- (2016) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Cortical-Bone Fragility — Insights from sFRP4 Deficiency in Pyle’s Disease
- (2016) Pelin O. Simsek Kiper et al. NEW ENGLAND JOURNAL OF MEDICINE
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study
- (2016) R. Rizzoli et al. OSTEOPOROSIS INTERNATIONAL
- Molecular Actions of Glucocorticoids in Cartilage and Bone During Health, Disease, and Steroid Therapy
- (2016) Kerstin Hartmann et al. PHYSIOLOGICAL REVIEWS
- Parathyroid Hormone-Related Protein, Its Regulation of Cartilage and Bone Development, and Role in Treating Bone Diseases
- (2016) T. John Martin PHYSIOLOGICAL REVIEWS
- Vertebral Implantation of NELL-1 Enhances Bone Formation in an Osteoporotic Sheep Model
- (2016) Aaron W. James et al. TISSUE ENGINEERING PART A
- SIKs control osteocyte responses to parathyroid hormone
- (2016) Marc N. Wein et al. Nature Communications
- A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair
- (2016) Monica Florio et al. Nature Communications
- The sclerostin-neutralizing antibody AbD09097 recognizes an epitope adjacent to sclerostin's binding site for the Wnt co-receptor LRP6
- (2016) V. Boschert et al. Open Biology
- Postmenopausal osteoporosis
- (2016) Richard Eastell et al. Nature Reviews Disease Primers
- Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2
- (2015) Amel Dudakovic et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Methylation of BoneSOST, Its mRNA, and Serum Sclerostin Levels Correlate Strongly With Fracture Risk in Postmenopausal Women
- (2015) Sjur Reppe et al. JOURNAL OF BONE AND MINERAL RESEARCH
- HDAC5 Controls MEF2C-Driven Sclerostin Expression in Osteocytes
- (2015) Marc N Wein et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density
- (2015) Robert R. Recker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Abaloparatide, a Human Parathyroid Hormone-Related Peptide Analog, on Bone Mineral Density in Postmenopausal Women with Osteoporosis
- (2015) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The WNT system: background and its role in bone
- (2015) U. H. Lerner et al. JOURNAL OF INTERNAL MEDICINE
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- (2015) Benjamin Z Leder et al. LANCET
- Short-term and long-term effects of osteoporosis therapies
- (2015) Ian R. Reid Nature Reviews Endocrinology
- Loss of sclerostin promotes osteoarthritis in mice via β-catenin-dependent and -independent Wnt pathways
- (2015) Wafa Bouaziz et al. ARTHRITIS RESEARCH & THERAPY
- NELL-1 in the treatment of osteoporotic bone loss
- (2015) Aaron W. James et al. Nature Communications
- Emerging therapeutic targets for osteoporosis treatment
- (2014) Minglei Chen et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical Toxicity of AZD7969
- (2014) A. P. Hall et al. TOXICOLOGIC PATHOLOGY
- Improvements in hip trabecular, subcortical, and cortical density and mass in postmenopausal women with osteoporosis treated with denosumab
- (2013) Harry K. Genant et al. BONE
- A signal-amplification circuit between miR-218 and Wnt/β-catenin signal promotes human adipose tissue-derived stem cells osteogenic differentiation
- (2013) Wei-Bing Zhang et al. BONE
- Single- and Multiple-Dose Randomized Studies of Blosozumab, a Monoclonal Antibody Against Sclerostin, in Healthy Postmenopausal Women
- (2013) Juliet McColm et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Effect of the Cathepsin K Inhibitor ONO-5334 on Trabecular and Cortical Bone in Postmenopausal Osteoporosis: The OCEAN Study
- (2013) Klaus Engelke et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of ONO-5334 on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis: 2-Year Results From the OCEAN Study
- (2013) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin
- (2013) Joachim Albers et al. JOURNAL OF CELL BIOLOGY
- Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
- (2013) Joy N Tsai et al. LANCET
- WNT signaling in bone homeostasis and disease: from human mutations to treatments
- (2013) Roland Baron et al. NATURE MEDICINE
- Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches
- (2013) Ernesto Canalis Nature Reviews Endocrinology
- Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday
- (2012) Michael McClung et al. AMERICAN JOURNAL OF MEDICINE
- Effects of PTH on osteocyte function
- (2012) Teresita Bellido et al. BONE
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- Sclerostin and Dickkopf-1 as Therapeutic Targets in Bone Diseases
- (2012) Hua Zhu Ke et al. ENDOCRINE REVIEWS
- miR-218 Directs a Wnt Signaling Circuit to Promote Differentiation of Osteoblasts and Osteomimicry of Metastatic Cancer Cells
- (2012) Mohammad Q. Hassan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study
- (2012) Bente Langdahl et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The US postmarketing surveillance study of adult osteosarcoma and teriparatide: Study design and findings from the first 7 years
- (2012) Elizabeth B Andrews et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Six Months of Parathyroid Hormone (1–84) Administered ConcurrentlyVersusSequentially with Monthly Ibandronate Over Two Years: The PTH and Ibandronate Combination Study (PICS) Randomized Trial
- (2012) Anne L. Schafer et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Benefits and Risks of Bisphosphonate Therapy for Osteoporosis
- (2012) Sundeep Khosla et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass
- (2012) Min Guan et al. NATURE MEDICINE
- Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
- (2012) David L. Lacey et al. NATURE REVIEWS DRUG DISCOVERY
- The epidemiology of osteoporosis and fractures in ankylosing spondylitis
- (2012) Philip N. Sambrook et al. Therapeutic Advances in Musculoskeletal Disease
- Wnt-inhibitory factor 1 dysregulation of the bone marrow niche exhausts hematopoietic stem cells
- (2011) C. Schaniel et al. BLOOD
- An Akt-dependent Increase in Canonical Wnt Signaling and a Decrease in Sclerostin Protein Levels Are Involved in Strontium Ranelate-induced Osteogenic Effects in Human Osteoblasts
- (2011) Mark S. Rybchyn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AMP-activated Protein Kinase Regulates β-Catenin Transcription via Histone Deacetylase 5
- (2011) Jun-Xing Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury
- (2011) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A Rate-Limiting Role for Dickkopf-1 in Bone Formation and the Remediation of Bone Loss in Mouse and Primate Models of Postmenopausal Osteoporosis by an Experimental Therapeutic Antibody
- (2011) H. Glantschnig et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis
- (2011) Aline G. Costa et al. Nature Reviews Rheumatology
- New targets for intervention in the treatment of postmenopausal osteoporosis
- (2011) E. Michael Lewiecki Nature Reviews Rheumatology
- AMP-activated protein kinase (AMPK) cross-talks with canonical Wnt signaling via phosphorylation of β-catenin at Ser 552
- (2010) Junxing Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-29 Modulates Wnt Signaling in Human Osteoblasts through a Positive Feedback Loop
- (2010) Kristina Kapinas et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of circulating sclerostin levels by sex steroids in women and in men
- (2010) Ulrike IL Mödder et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis
- (2010) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Nell-1, a key functional mediator of Runx2, partially rescues calvarial defects in Runx2+/− mice
- (2010) Xinli Zhang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab
- (2010) René Rizzoli et al. NATURE REVIEWS DRUG DISCOVERY
- Lasofoxifene in Postmenopausal Women with Osteoporosis
- (2010) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of Akt1 in terminal stages of endochondral bone formation: Angiogenesis and ossification
- (2009) Veronica Ulici et al. BONE
- Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
- (2009) Bryan T. MacDonald et al. DEVELOPMENTAL CELL
- Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women
- (2009) Robert Lindsay et al. FERTILITY AND STERILITY
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functions of RANKL/RANK/OPG in bone modeling and remodeling
- (2008) Brendan F. Boyce et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- The role of Dickkopf-1 in bone development, homeostasis, and disease
- (2008) J. J. Pinzone et al. BLOOD
- Mesodermal fate decisions of a stem cell: the Wnt switch
- (2008) L. A. Davis et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease
- (2008) Ann E. Kearns et al. ENDOCRINE REVIEWS
- Parathyroid hormone signaling through low-density lipoprotein-related protein 6
- (2008) M. Wan et al. GENES & DEVELOPMENT
- Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial*
- (2008) Stuart L Silverman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts
- (2007) Chih-Hsin Tang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started